http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110124041-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7036 |
| filingDate | 2019-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110124041-B |
| titleOfInvention | Pharmaceutical composition capable of resisting retention bacteria and biofilm bacteria and application thereof |
| abstract | The invention relates to a pharmaceutical composition capable of resisting persistent bacteria and biofilm bacteria and application thereof, wherein the active ingredients of the pharmaceutical composition capable of resisting the persistent bacteria and the biofilm bacteria comprise: at least one of a DNA synthesis inhibitor-based antibiotic, a cell wall inhibitor-based antibiotic, and a protein inhibitor-based antibiotic; the application of the pharmaceutical composition in preparing a reagent or a kit is to kill infection, chronic persistent infection and biofilm infection caused by pseudomonas aeruginosa; the pharmaceutical composition can rapidly and thoroughly eliminate pseudomonas aeruginosa continuously infecting the lung by combining clinafloxacin, cefuroxime and gentamicin, and has obvious treatment effect on chronic continuous infection and biofilm infection caused by pseudomonas aeruginosa. |
| priorityDate | 2019-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.